Turku, Finland

H Kalervo Väänänen


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal1 out of 832,912 
Other
 patents

Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: H Kalervo Väänänen: Innovator in Bone Fracture Prediction

Introduction

H Kalervo Väänänen is a notable inventor based in Turku, Finland. He has made significant contributions to the field of medical diagnostics, particularly in assessing bone health. His innovative approach focuses on predicting bone fractures through specific biochemical measurements.

Latest Patents

Väänänen holds a patent for a method that predicts bone fractures by measuring osteocalcin levels. This invention addresses the assessment of bone fragility and fracture risk, particularly in individuals at risk of osteoporosis. The method involves measuring the concentration of gamma-carboxylated osteocalcin (COC) in a body fluid sample and comparing it to the mean concentration in a similar demographic. A lower concentration of COC indicates a higher risk of osteoporosis and fractures.

Career Highlights

Throughout his career, Väänänen has dedicated himself to advancing medical technology and improving patient outcomes. His work has been instrumental in developing non-invasive methods for assessing bone health, which can lead to better preventative care strategies.

Collaborations

Väänänen has collaborated with notable colleagues, including Sanna-Maria Käkönen and Heikki Luukinen. These partnerships have fostered a collaborative environment that enhances research and innovation in the field of bone health.

Conclusion

H Kalervo Väänänen's contributions to the field of medical diagnostics through his innovative patent demonstrate his commitment to improving healthcare. His work in predicting bone fractures is a significant advancement that can lead to better management of osteoporosis and related conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…